background


Product Information:

Remdesivir

Remdesivir is highly effective in the control of 2019-nCoV (COVID-19) infection in vitro. Remdesivir (GS-5734) is a nucleoside analogue, with effective antiviral activity, with EC50s of 74 nM for SARS-CoV and MERS-CoV in HAE cells, and 30 nM for murine hepatitis virus in delayed brain tumor cells.

Cat. No.: EX-A3265    Purity: 99.99%
For research only, Do not use for Human!

SizeUnit Price (US$)StockQuantityOrder
50mg250In-stock
100mg450In-stock
250mg650In-stock
500mg900In-stock
1g1350In-stock


SynonymsGS-5734
CAS No.1809249-37-3
Purity99.99%
FormulaC27H35N6O8P
Mol Weight602.576
Appearancewhite solid powder
SolubilityDMSO >100mg/mL
Shelf Life>2 years if stored properly
StoragePowder -20℃ 2 years; In solvent -20℃ 1 month;
ShippingShipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
 
 
Reference:  [1]. Wang M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 Mar;30(3):269-271.

[2]. Agostini ML, et al. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease. MBio. 2018 Mar 6;9(2). pii: e00221-18.
CoACoA of Remdesivir
HNMRHNMR of Remdesivir
HPLC/LC-MSLCMS/HPLC of Remdesivir
Smiles:C[C@H](N[P@@](OC1=CC=CC=C1)(OC[C@H]2O[C@@](C#N)(C3=CC=C4C(N)=NC=NN43)[C@H](O)[C@@H]2O)=O)C(OCC(CC)CC)=O